Completed OBSERVATIONAL NCT02997046

Ferumoxytol Enhanced Magnetic Resonance Angiography in Chronic Kidney Disease (FeMRA in CKD)

Use of Ferumoxytol Enhanced Magnetic Resonance Angiography for Cardiovascular Assessment in Late-stage Chronic Kidney Disease

Sponsor: NHS Greater Glasgow and Clyde

Conditions Arteriovenous Fistula Ferric Compounds Kidney Transplantation Magnetic Resonance Angiography Vascular Grafting

Updated 8 times since 2017 Last updated: Feb 8, 2019 Started: Dec 12, 2016 Primary completion: Sep 1, 2018 Completion: Sep 1, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Arteriovenous Fistula and Ferric Compounds, this trial is completed. The trial is conducted by NHS Greater Glasgow and Clyde and has accumulated 8 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Mar 2019 — Jan 2021 [monthly]

Completed

Status: Unknown Status → Completed · Phase: PHASE4 → None
Jan 2019 — Mar 2019 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Jun 2018 — Jan 2019 [monthly]

Recruiting PHASE4
Feb 2017 — Jun 2018 [monthly]

Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE4

First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NHS Greater Glasgow and Clyde
Sokratis Stoumpos

Data source: University of Glasgow

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Glasgow, United Kingdom